Grant: Alliance Grants
The University of Western Ontario
$30,000.00
Development of a user-friendly software to predict the formation of pharmaceutical cocrystals
FY 2023-24
Summary
Many solid active pharmaceutical ingredients (APIs) have poor solubility in the human body and as such limited bioavailability. If the API molecule is neutral and not ionizable, an attractive way to improve its solubility is to form a cocrystal with an auxiliary molecule (coformer). Cocrystals are a subcategory of multi-component crystals. Pharmaceutical cocrystals are relatively new. The present proposal aims at developing a user-friendly software model to enable the theoretical prediction of the formation of a pharmaceutical cocrystal for a given active pharmaceutical ingredient (API) with a coformer molecule. The coformer molecules are screened using the proposed software package from among 2000 molecules with low toxicity in the Generally Recognized as Safe (GRAS) list and an additional 1000 compounds in the Everything Added to Food. The software package will enable the user to screen ten to twenty safe coformer molecules capable of successfully forming a cocrystal with the given API. Small scale liquid assisted grinding experiments will be conducted on the suggested ten to twenty coformer molecules with the given API to ensure the predictive capability of the proposed model. The model (software) uses the Cambridge Structural Database as the input data source and uses molecular dynamic simulation and artificial intelligence to perform the screening task. The proposed predictive software package enables the Canadian pharmaceutical industry to develop pharmaceuticals with higher efficacy and bioavailability at a faster rate and more economical without having to conduct extensive experimental work. Consequently, the Canadian public will benefit from more efficacious pharmaceutical products at lower cost.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
587055-2023
Name nom
Rohani, Sohrab S
Department département
Chemical and Biochemical Engineering
Organization id
36
Institution établissement
The University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
1806
Research subject group en
Chemical engineering
Research subject group fr
Separation processes
Research subject en
Génie chimique
Research subject fr
Procédés de séparation
Application title
Development of a user-friendly software to predict the formation of pharmaceutical cocrystals
Keyword
Active pharmaceutical ingredients; Artificial neural networks; A user-friendly software; Deep learning; Electronic surface potential map; Experimental validation; Molecular dynamic simulation; Pharmaceutical cocrystals; PointNet; Prediction
Application summary
Many solid active pharmaceutical ingredients (APIs) have poor solubility in the human body and as such limited bioavailability. If the API molecule is neutral and not ionizable, an attractive way to improve its solubility is to form a cocrystal with an auxiliary molecule (coformer). Cocrystals are a subcategory of multi-component crystals. Pharmaceutical cocrystals are relatively new. The present proposal aims at developing a user-friendly software model to enable the theoretical prediction of the formation of a pharmaceutical cocrystal for a given active pharmaceutical ingredient (API) with a coformer molecule. The coformer molecules are screened using the proposed software package from among 2000 molecules with low toxicity in the Generally Recognized as Safe (GRAS) list and an additional 1000 compounds in the Everything Added to Food. The software package will enable the user to screen ten to twenty safe coformer molecules capable of successfully forming a cocrystal with the given API. Small scale liquid assisted grinding experiments will be conducted on the suggested ten to twenty coformer molecules with the given API to ensure the predictive capability of the proposed model. The model (software) uses the Cambridge Structural Database as the input data source and uses molecular dynamic simulation and artificial intelligence to perform the screening task. The proposed predictive software package enables the Canadian pharmaceutical industry to develop pharmaceuticals with higher efficacy and bioavailability at a faster rate and more economical without having to conduct extensive experimental work. Consequently, the Canadian public will benefit from more efficacious pharmaceutical products at lower cost.